Session Details
[[A]D401-2vn]17. Biofunctional Chemistry, Biotechnology
Thu. Mar 27, 2025 3:55 PM - 5:15 PM JST
Thu. Mar 27, 2025 6:55 AM - 8:15 AM UTC
Thu. Mar 27, 2025 6:55 AM - 8:15 AM UTC
[A]D401(D401, Bldg. 4, Area 3 [4F])
[[A]D401-2vn-01]Transcription system based on enhancement of chemical ligation by nucleic acid with chirality
○Hikari Okita1, Keiji Murayama1, Hiroyuki Asanuma1 (1. Nagoya Univ.)
[[A]D401-2vn-02]Anti-tumor Effect of Anti-miR21 designed with acyclic artificial nucleic acids.
○Hiroyuki Asanuma1, Sato Fuminori1, Kiyoka Sakashita1, Xueying Liu2, Kinoh Hiroaki2, Kazunori Kataoka2, Yukiko Kamiya3 (1. Graduate School of Engineering, Nagoya University, 2. Innovation Center of NanoMedicine, 3. Kobe Pharmaceutical University)
[[A]D401-2vn-03]G-quadruplex topology-selective liquid-liquid phase separation
○Mitsuki Tsuruta1, Shil Sumit1, Keiko Kawauchi1, Daisuke Miyoshi1 (1. FIRST, Konan University)
[[A]D401-2vn-04]NRAS DNA G-quadruplex ligands for sequence-selective enzyme inhibition
○Yoshiki Hashimoto1, Hiroki Kubo1, Keiko Kawauchi1, Daisuke Miyoshi1 (1. FIRST, Konan University)